Levels of the ligand, CXCL12, are elevated in IPF patients and both primary iPAH and secondary PH (Mehrad et al. 2007; Andersson‐Sjoland et al. 2008; Yeager et al. 2012). Here, CXCL12 is linked to idiopathic pulmonary arterial hypertension.